HIV 1 News and Research

RSS

AIDS breakthrough - vaccine strengthens the body’s immune system againts HIV

A Hadassah University Medical Center research team has developed a vaccine that significantly strengthens the body’s immune system against the autoimmune sequela of HIV infection, a breakthrough that could dramatically make an impact in the treatment of AIDS patients.

28 Dec 2004

Researchers can now inexpensively program the chemical synthesis of entire genes on a single microchip

Devices the size of a pager now have greater capabilities than computers that once occupied an entire room. Similar advances are being made in the emerging field of synthetic biology at the University of Houston, now allowing researchers to inexpensively program the chemical synthesis of entire genes on a single microchip.

23 Dec 2004

Theory that could help to cure diseases including cancer

An Open University science student has astonished the world of medicine with a theory that could help to cure diseases including cancer.

21 Dec 2004

20 new policies adopted by American Public Health Association

The American Public Health Association recently adopted 20 policies addressing a broad range of issues in public health from underage alcohol consumption and nutrition labeling in restaurants to the supply of flu vaccinations and threats to immigrants’ health care.

21 Dec 2004

The burgeoning Indian AIDS epidemic

India, home to one-sixth of the human race, has an AIDS epidemic. Five million Indians are living with HIV infection. The stakes are high; the government is racing against time.

21 Dec 2004

Framework responding to the growing need for guidance on HIV and AIDS in African communities

A framework responding to the growing need for guidance on HIV and AIDS in African communities was launched today by Public Health Minister Melanie Johnson.

20 Dec 2004

Risk of tuberculosis infection doubles within one year of HIV infection

Scientists previously assumed that there was no increase in tuberculosis risk within the first few years of HIV infection. Pam Sonnenberg of the London School of Hygiene and Tropical Medicine and colleagues were therefore surprised by the results of their research on the two infections, which they conducted in South African gold miners.

20 Dec 2004

Key advance in understanding the proteins and mechanisms involved in the spread of Lyme Disease

Virginia Commonwealth University scientists have made a key advance in understanding the proteins and mechanisms involved in the spread of Lyme Disease, a finding that could lead to a vaccine against the tick-borne illness that affects thousands of people each year.

16 Dec 2004

Scientists have identified a novel anti-tuberculosis (TB) compound

Scientists at Johnson & Johnson Pharmaceutical Research and Development have identified a novel anti-tuberculosis (TB) compound that works better and faster than the current standard of care in mouse models of TB infection.

14 Dec 2004

Safety of AIDS drug to prevent mother-to-child transmission of HIV questioned

In light of several recent drug industry scandals roiling the nation's public health and raising serious questions about the US bodies that license and regulate the industry -- and startling new revelations today concerning National Institutes of Health (NIH) officials and the safety of a brand name AIDS drug used to prevent mother-to-child transmission of the HIV

14 Dec 2004

Targeted screening of high-risk groups for genital herpes may prevent disease transmission

Identifying asymptomatic people with genital herpes infection through targeted screening of high-risk groups may prevent disease transmission. However, widespread screening of pregnant women is unlikely to reduce the occurrence of herpes in newborns, according to an article in the January 1 issue of Clinical Infectious Diseases, now available online.

13 Dec 2004

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

A team of researchers based partly in South Africa has identified a key set of immune system molecules that helps determine how effectively a person resists infection with human immunodeficiency virus (HIV).

8 Dec 2004

New technology will advance our understanding of role of complex sugar chains decorating the surface of cells in the body

An international consortium of scientists lead by Dr. James Paulson of The Scripps Research Institute has created a technology that will advance our understanding of the role of complex sugar chains (glycans or carbohydrates) that decorate the surface of cells in the body.

8 Dec 2004

African health care systems: what went wrong?

The last century witnessed unparalleled improvements in the health indicators of many countries in the African Region, particularly reductions in child mortality.

8 Dec 2004

Thalidomide shows promise in fighting myeloma

Thalidomide, a drug often used to treat symptoms of leprosy and in testing to fight HIV, is now demonstrating activity in fighting a common cancer that occurs in bone marrow, myeloma.

6 Dec 2004

Scientist develops way to deliver promising genetic tool into living cells

By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.

6 Dec 2004

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).

6 Dec 2004

More than 11 million children in developing countries die every year from preventable illness

More than 11 million children in developing countries die every year from preventable illness, while as many as 500 000 women don't survive during pregnancy or childbirth. More than 39 million people are living with HIV/AIDS and the epidemic is growing.

4 Dec 2004

Human endogenous retroviruses (HERVs)

Human endogenous retroviruses (HERVs) have been the subject of a great deal of investigation in recent years. It has been established that HERVs cause some genetic diseases and there is strong circumstantial evidence for a link to some types of cancer and autoimmune diseases, but what else do we need to know about these unique organisms?

4 Dec 2004

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.

4 Dec 2004

HIV 1 News and Research

AIDS breakthrough - vaccine strengthens the body’s immune system againts HIV

Researchers can now inexpensively program the chemical synthesis of entire genes on a single microchip

Theory that could help to cure diseases including cancer

20 new policies adopted by American Public Health Association

The burgeoning Indian AIDS epidemic

Framework responding to the growing need for guidance on HIV and AIDS in African communities

Risk of tuberculosis infection doubles within one year of HIV infection

Key advance in understanding the proteins and mechanisms involved in the spread of Lyme Disease

Scientists have identified a novel anti-tuberculosis (TB) compound

Safety of AIDS drug to prevent mother-to-child transmission of HIV questioned

Targeted screening of high-risk groups for genital herpes may prevent disease transmission

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

New technology will advance our understanding of role of complex sugar chains decorating the surface of cells in the body

African health care systems: what went wrong?

Thalidomide shows promise in fighting myeloma

Scientist develops way to deliver promising genetic tool into living cells

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

More than 11 million children in developing countries die every year from preventable illness

Human endogenous retroviruses (HERVs)

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News